LINC01116 has been reported to be an oncogene in multiple cancers (Xu et al., 2017; Hu et al., 2018; Ye et al., 2020), including osteosarcoma (Zhang et al., 2018; Zhang et al., 2019b). This evidence concerns the gene LINC01116 and osteosarcoma.